コンテンツへスキップ
Merck
  • An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.

An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.

Cancer cell (2020-01-15)
Jermaine Goveia, Katerina Rohlenova, Federico Taverna, Lucas Treps, Lena-Christin Conradi, Andreas Pircher, Vincent Geldhof, Laura P M H de Rooij, Joanna Kalucka, Liliana Sokol, Melissa García-Caballero, Yingfeng Zheng, Junbin Qian, Laure-Anne Teuwen, Shawez Khan, Bram Boeckx, Els Wauters, Herbert Decaluwé, Paul De Leyn, Johan Vansteenkiste, Birgit Weynand, Xavier Sagaert, Erik Verbeken, Albert Wolthuis, Baki Topal, Wouter Everaerts, Hanibal Bohnenberger, Alexander Emmert, Dena Panovska, Frederik De Smet, Frank J T Staal, Rene J Mclaughlin, Francis Impens, Vincenzo Lagani, Stefan Vinckier, Massimiliano Mazzone, Luc Schoonjans, Mieke Dewerchin, Guy Eelen, Tobias K Karakach, Huanming Yang, Jian Wang, Lars Bolund, Lin Lin, Bernard Thienpont, Xuri Li, Diether Lambrechts, Yonglun Luo, Peter Carmeliet
要旨

Heterogeneity of lung tumor endothelial cell (TEC) phenotypes across patients, species (human/mouse), and models (in vivo/in vitro) remains poorly inventoried at the single-cell level. We single-cell RNA (scRNA)-sequenced 56,771 endothelial cells from human/mouse (peri)-tumoral lung and cultured human lung TECs, and detected 17 known and 16 previously unrecognized phenotypes, including TECs putatively regulating immune surveillance. We resolved the canonical tip TECs into a known migratory tip and a putative basement-membrane remodeling breach phenotype. Tip TEC signatures correlated with patient survival, and tip/breach TECs were most sensitive to vascular endothelial growth factor blockade. Only tip TECs were congruent across species/models and shared conserved markers. Integrated analysis of the scRNA-sequenced data with orthogonal multi-omics and meta-analysis data across different human tumors, validated by functional analysis, identified collagen modification as a candidate angiogenic pathway.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
デオキシリボヌクレアーゼ I ウシ膵臓由来, Type II, lyophilized powder, Protein ≥80 %, ≥2,000 units/mg protein
Sigma-Aldrich
メチルセルロース, viscosity: 4,000 cP
Sigma-Aldrich
I型コラーゲン、ラット尾部, 100 mg, solution, BioReagent, suitable for cell culture
Sigma-Aldrich
ゼラチン ウシ皮膚由来, Type B, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
ウシ血清アルブミン ウシ血清由来, lyophilized powder, essentially IgG-free, low endotoxin, BioReagent, suitable for cell culture
Sigma-Aldrich
抗アクチンα-平滑筋-FITC抗体、マウスモノクローナル マウス宿主抗体, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
ミノキシジル, ≥99% (TLC)
Sigma-Aldrich
3-アミノプロピオニトリル フマル酸塩, metabolite
Sigma-Aldrich
L-(−)-グルコース, ≥99%
Sigma-Aldrich
3-amino-propionitrile, AldrichCPR
Sigma-Aldrich
ビスベンズイミド H 33342 三塩酸塩, ≥98% (HPLC and TLC)
Sigma-Aldrich
抗EFNB2抗体 ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
抗SELP抗体 ウサギ宿主抗体, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution